223 related articles for article (PubMed ID: 30608051)
1. Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials.
Oldenburg CE; Arzika AM; Amza A; Gebre T; Kalua K; Mrango Z; Cotter SY; West SK; Bailey RL; Emerson PM; O'Brien KS; Porco TC; Keenan JD; Lietman TM
Am J Trop Med Hyg; 2019 Mar; 100(3):691-695. PubMed ID: 30608051
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.
Keenan JD; Bailey RL; West SK; Arzika AM; Hart J; Weaver J; Kalua K; Mrango Z; Ray KJ; Cook C; Lebas E; O'Brien KS; Emerson PM; Porco TC; Lietman TM;
N Engl J Med; 2018 Apr; 378(17):1583-1592. PubMed ID: 29694816
[TBL] [Abstract][Full Text] [Related]
3. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions.
Porco TC; Oldenburg CE; Arzika AM; Kalua K; Mrango Z; Cook C; Lebas E; Bailey RL; West SK; Oron AP; Keenan JD; Lietman TM; For The Mordor Study Group
Am J Trop Med Hyg; 2020 Sep; 103(3):1291-1294. PubMed ID: 30734695
[TBL] [Abstract][Full Text] [Related]
5. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T;
PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718
[TBL] [Abstract][Full Text] [Related]
6. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
[TBL] [Abstract][Full Text] [Related]
7. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial.
Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin distribution and childhood mortality in compliance-related subgroups in Niger: complier average causal effect and spillovers in a cluster-randomized, placebo-controlled trial.
O'Brien KS; Arzika AM; Maliki R; Amza A; Manzo F; Mankara AK; Lebas E; Cook C; Oldenburg CE; Porco TC; Arnold BF; Bertozzi S; Keenan JD; Lietman TM
Int J Epidemiol; 2022 Dec; 51(6):1775-1784. PubMed ID: 34508582
[TBL] [Abstract][Full Text] [Related]
9. Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.
Keenan JD; Arzika AM; Maliki R; Boubacar N; Elh Adamou S; Moussa Ali M; Cook C; Lebas E; Lin Y; Ray KJ; O'Brien KS; Doan T; Oldenburg CE; Callahan EK; Emerson PM; Porco TC; Lietman TM
N Engl J Med; 2019 Jun; 380(23):2207-2214. PubMed ID: 31167050
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial.
Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840
[TBL] [Abstract][Full Text] [Related]
11. Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.
O'Brien KS; Arzika AM; Maliki R; Manzo F; Mamkara AK; Lebas E; Cook C; Bailey RL; West SK; Oldenburg CE; Porco TC; Arnold B; Keenan JD; Lietman TM;
PLoS Med; 2020 Sep; 17(9):e1003285. PubMed ID: 32931496
[TBL] [Abstract][Full Text] [Related]
12. Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
Porco TC; Hart J; Arzika AM; Weaver J; Kalua K; Mrango Z; Cotter SY; Stoller NE; O'Brien KS; Fry DM; Vanderschelden B; Oldenburg CE; West SK; Bailey RL; Keenan JD; Lietman TM;
Clin Infect Dis; 2019 May; 68(12):2114-2116. PubMed ID: 30561577
[TBL] [Abstract][Full Text] [Related]
13. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial.
Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841
[TBL] [Abstract][Full Text] [Related]
14. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.
Arzika AM; Maliki R; Boubacar N; Kane S; Cotter SY; Lebas E; Cook C; Bailey RL; West SK; Rosenthal PJ; Porco TC; Lietman TM; Keenan JD;
PLoS Med; 2019 Jun; 16(6):e1002835. PubMed ID: 31237871
[TBL] [Abstract][Full Text] [Related]
15. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial.
Adubra L; Alber D; Ashorn P; Ashorn U; Cheung YB; Cloutman-Green E; Diallo F; Ducker C; Elovainio R; Fan YM; Gates L; Gruffudd G; Haapaniemi T; Haidara F; Hallamaa L; Ihamuotila R; Klein N; Luoma J; Martell O; Sow S; Vehmasto T;
Trials; 2023 Jan; 24(1):5. PubMed ID: 36597115
[TBL] [Abstract][Full Text] [Related]
16. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).
O'Brien KS; Arzika AM; Amza A; Maliki R; Ousmane S; Kadri B; Nassirou B; Mankara AK; Harouna AN; Colby E; Lebas E; Liu Z; Le V; Nguyen W; Keenan JD; Oldenburg CE; Porco TC; Doan T; Arnold BF; Lietman TM;
BMC Public Health; 2021 Apr; 21(1):822. PubMed ID: 33926403
[TBL] [Abstract][Full Text] [Related]
17. Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial.
Bloch EM; Mrango Z; Weaver J; Munoz B; Lietman TM; West SK
PLoS One; 2021; 16(9):e0250197. PubMed ID: 34559801
[TBL] [Abstract][Full Text] [Related]
18. Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial.
Oldenburg CE; Ouattara M; Bountogo M; Boudo V; Ouedraogo T; Compaoré G; Dah C; Zakane A; Coulibaly B; Bagagnan C; Hu H; O'Brien KS; Nyatigo F; Keenan JD; Doan T; Porco TC; Arnold BF; Lebas E; Sié A; Lietman TM
JAMA; 2024 Feb; 331(6):482-490. PubMed ID: 38349371
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution.
Oldenburg CE; Arzika AM; Maliki R; Lin Y; O'Brien KS; Keenan JD; Lietman TM; For The Mordor Study Group
Am J Trop Med Hyg; 2020 Sep; 103(3):1308-1310. PubMed ID: 32067626
[TBL] [Abstract][Full Text] [Related]
20. Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial.
Arzika AM; Maliki R; Ali MM; Alio MK; Abdou A; Cotter SY; Varnado NE; Lebas E; Cook C; Oldenburg CE; O'Brien KS; Callahan EK; Bailey RL; West SK; Porco TC; Lietman TM; Keenan JD;
JAMA Netw Open; 2021 Dec; 4(12):e2139351. PubMed ID: 34967883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
